The paper is short, but a number of the patients had prior immunotherapy treatments (not all, and the rates are broken out by treatment, not by cancer stage.) The paper also does not seem to include the 0% survival rate for the Stage IV placebo group. (Or I missed it.)
I am making up things, but it is possible that other treatments had already failed and this was a “hail marry” for the Stage IV people.